Exelixis, Inc. (EXEL) Tops Q2 EPS by 1c; Raises FY11 Sales Guidance
Exelixis, Inc. (NASDAQ: EXEL) reported Q2 EPS of ($0.16), $0.01 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $32.2 million versus the consensus estimate of $37.47 million.
Sees FY2011 revenue of $220-$250 million, versus prior guidance of $145-$160 million and the consensus of $166.3 million.
Sees FY2011 revenue of $220-$250 million, versus prior guidance of $145-$160 million and the consensus of $166.3 million.